Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0557 | 0.4967 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0222 | 1 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.005 | 0.0141 | 0.6346 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Toxoplasma gondii | hypothetical protein | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0059 | 0.0222 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0557 | 0.4967 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0059 | 0.0222 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0051 | 0.0146 | 0.6584 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0051 | 0.0146 | 0.0651 |
Trichomonas vaginalis | ABC transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Entamoeba histolytica | hypothetical protein | 0.0059 | 0.0222 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0222 | 1 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0059 | 0.0222 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0051 | 0.0146 | 0.6584 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0051 | 0.0146 | 0.6584 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0059 | 0.0222 | 1 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.0059 | 0.0222 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | hypothetical protein | 0.0059 | 0.0222 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0051 | 0.0146 | 0.5 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0051 | 0.0146 | 0.6584 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0059 | 0.0222 | 1 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | abcb9, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | taga, putative | 0.0051 | 0.0146 | 0.6584 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0222 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0059 | 0.0222 | 0.0077 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0222 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0051 | 0.0146 | 0.5 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Entamoeba histolytica | hypothetical membrane-spanning protein | 0.0059 | 0.0222 | 0.0077 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0557 | 0.4967 | 0.5 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0051 | 0.0146 | 0.6584 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0557 | 0.4967 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0146 | 0.0651 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0051 | 0.0146 | 0.0651 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | ABC transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0059 | 0.0222 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0059 | 0.0222 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0051 | 0.0146 | 0.6584 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0059 | 0.0222 | 1 |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.0059 | 0.0222 | 1 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.005 | 0.0141 | 0.6346 |
Onchocerca volvulus | 0.0051 | 0.0146 | 0.5 | |
Trichomonas vaginalis | ABC transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Entamoeba histolytica | hypothetical protein | 0.0059 | 0.0222 | 0.0077 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0051 | 0.0146 | 0.6584 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0051 | 0.0146 | 0.6584 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0557 | 0.4967 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0051 | 0.0146 | 0.6584 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0059 | 0.0222 | 1 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.0059 | 0.0222 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0051 | 0.0146 | 0.6584 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0222 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0059 | 0.0222 | 0.0077 |
Entamoeba histolytica | hypothetical protein | 0.0059 | 0.0222 | 0.0077 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0051 | 0.0146 | 0.6584 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 3 | 0.0059 | 0.0222 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0051 | 0.0146 | 0.6584 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0146 | 0.0651 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0051 | 0.0146 | 0.6584 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.